Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate and Etonogestrel Implant Quickstart Pharmacodynamics
NCT04291001Phase 1Completed
- Sponsor
- University of Utah
- Start
- Sep 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ulipristal in contraception (2 arms), sponsored by University of Utah. Primary endpoints: Number of Participants With Ovulation With Implant-alone at 5 days and Number of Participants With Ovulation With Implant and Same Day UPA at 5 days. Started Sep 2020; status: completed.
02
Drugs
ulipristal
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04291001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04291001.